Determinants of outcome following surgery for oral squamous cell carcinoma

Future Oncology

Volumn 5, Issue 1, 2009, Pages 51-61

  Woolgar, Julia A ^a   Hall, Gillian L ^a  

^a LIVERPOOL UNIVERSITY DENTAL HOSPITAL   (United Kingdom)

Author keywords

Histopathology; Oral cavity cancer; Outcome following surgery; Prognosticators; Squamous cell carcinoma

Indexed keywords

CETUXIMAB;

BONE METASTASIS; CANCER GRADING; CANCER INCIDENCE; CANCER INVASION; CANCER MORPHOLOGY; CANCER MORTALITY; CANCER RELAPSE; CANCER STAGING; CLINICAL TRIAL; COMORBIDITY; DISEASE FREE SURVIVAL; DISTANT METASTASIS; HEAD AND NECK CANCER; HISTOPATHOLOGY; HUMAN; LIFESTYLE; LYMPH NODE METASTASIS; MICROMETASTASIS; MOUTH CARCINOMA; NECK DISSECTION; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; RACE DIFFERENCE; REVIEW; SEX DIFFERENCE; SKIN METASTASIS; SOCIAL SUPPORT; SOCIOECONOMICS; SQUAMOUS CELL CARCINOMA; MOUTH TUMOR; ORAL SURGERY; PATHOLOGY; RISK FACTOR; TREATMENT OUTCOME;

CARCINOMA, SQUAMOUS CELL; HUMANS; MOUTH NEOPLASMS; ORAL SURGICAL PROCEDURES; PROGNOSIS; RISK FACTORS; TREATMENT OUTCOME;

EID: 65349109857     PISSN: 14796694     EISSN: 17448301     Source Type: Journal    
DOI: 10.2217/14796694.5.1.51     Document Type: Review

References (124)

1. Shah JP: Surgical approaches to the oral cavity primary and neck. Int. J. Radiat. Oncol. Biol. Phys. 69(2 Suppl.), S15-S18 (2007).
2. Katre C, Johnson IA, Humphris GM, Lowe D, Rogers SN: Assessment of problems with appearance following surgery for oral and oropharyngeal cancer using the University of Washington appearance domain and the Derriford appearance scale. Oral Oncol. 44(10), 927-934 (2008).
3. Bokhari WA, Wang SJ: Tongue reconstruction: recent advances. Curr. Opin. Otolaryngol-Head Neck Surg. 15(4), 202-207 (2007).
4. Sobin LH, Wittekind Ch: UICC TNM Classification of malignant tumours. 6th Edition. Wiley-Liss, NY, USA (2002).
5. Rogers SN, Brown JS, Woolgar JA et al.: Survival following primary surgery for oral cancer: a regional unit's experience in the UK. Oral Oncol. PMID 18674959 (2008) (Epub ahead of print).
6. Rossi V, Tarozzi M, Lodi G, Sardella A, Demarosi F, Carrassi A: Clinical aspects and survival rates in subjects with oral cancer: a retrospective cohort study. Minerva Stomatol. 56(11-12), 591-601 (2007).
7. Funk GF, Karnell LH, Robinson RA, Zhen WK, Trask DK, Hoffman HT: Presentation, treatment and outcome of oral cavity cancer: a national cancer database report. Head Neck 24(2), 165-180 (2002).
8. Bhattacharyya N: A matched survival analysis for squamous cell carcinoma of the head and neck in the elderly. Laryngoscope 113(2), 368-372 (2003).
9. Verschuur HP, Irish JC, O'Sullivan B, Goh C, Gullane PJ, Pintilie M: A matched control study of treatment outcomes in young patients with squamous-cell carcinoma of the head and neck. Laryngoscope 109(2 Part 1), 249-258 (1999).
10. Siegelmann-Danieli N, Hanlon A, Ridge JA, Padmore R, Fein DA, Langer CJ: Oral tongue cancer in patients less than 45 years old: institutional experience and comparison with older patients. J Clin Oncol. 16(2), 745-753 (1998).
11. Veness MJ, Morgan GJ, Sathiyaseelan Y, Gebski V: Anterior tongue cancer: age is not a predictor of outcome and should not alter treatment. ANZ J. Surg. 73(11), 899-904 (2003).
12. Sasaki T, Moles DR, Imai Y, Speight PM: Clinico-pathological features of squamous cell carcinoma of the oral cavity of young people. J. Oral Path. Med. 34(3), 129-133 (2005).
13. Langdon JD, Rapidis AD: Oral cancer and sex - why do females do better? J. Maxillofac. Surg. 7(3), 177-181 (1979).
14. Franco EL, Dib LL, Pinto DS: Race and gender influences on the survival of patients with mouth cancer. J. Clin. Epidemiol. 46(1), 37-46 (1993).
15. Garavello W, Spreafico R, Somigliana E, Gaini L, Pignataro L, Gaini RM: Prognostic influence of gender in patients with oral tongue cancer. Otolaryngol. Head Neck Surg. 138(6), 768-771 (2008).
16. Moore RJ, Doherty DA, Do KA, Chamberlain RM, Khuri FR: Racial disparity in survival of patients with squamous cell carcinoma of the oral cavity and pharynx. Ethn. Health 6(3-4), 165-177 (2001).
17. Nichols AC, Bhattacharyya N: Racial differences in stage and survival in head and neck squamous cell carcinoma. Laryngoscope 117(5), 770-775 (2007).
18. Shiboski CH, Schmidt BL, Jordan RC: Racial disparity in stage at diagnosis and survival amongst adults with oral cancer in the US. Community Dent. Oral Epidemiol. 35(3), 233-240 (2007).
19. Gourin CG, Podolsky RH: Racial disparities in patients with head and neck squamous cell carcinoma. Laryngoscope 116(7), 1093-1106 (2006).
20. Johnson N: Tobacco use and oral cancer: a global perspective. J. Dent. Educ. 65(4), 328-339 (2001).
21. Hindle I, Downer MC, Doles DR, Speight PM: Is alcohol responsible for more intra-oral cancer? Oral Oncol. 36(4), 328-333 (2000).
22. Hindle I, Downer MC, Speight PM: The association between intra-oral cancer and surrogate markers of smoking and alcohol consumption. Community Dent. Health 17(2), 107-113 (2000).
23. Reid BC, Alberg AJ, Klassen AC et al.: Comorbidity and survival of elderly head and neck carcinoma patients. Cancer 92(8), 2109-2116 (2001).
24. Piccirillo JF, Lacey PD, Basu A, Spitznagel EL: Development of a new head and neck cancer-specific comorbidity index.. Arch. Otolaryngol. Head Neck Surg. 128(10), 1172-1179 (2002).
25. De Cassia Braga Ribeiro K, Kowalski LP, Latorre Mdo R: Perioperative complications, comorbidities and survival in oral or oropharyngeal cancer. Arch. Otolaryngol. Head Neck Surg. 129(2), 219-228 (2003).
26. Piccirillo JF: Importance of comorbidity in head and neck cancer. Laryngoscope 110(4), 593-602 (2000).
27. Borggreven PA, Kuik DJ, Langendijk JA, Doornaert P, de Bree R, Leemans CR: Severe comorbidity negatively influences prognosis in patients with oral and oropharyngeal cancer after surgical treatment with microvascula reconstruction. Oral Oncol. 41(4), 358-364 (2005).
28. Singh B, Cordeiro PG, Santamaria E, Shaba AR, Pfister DG, Shah JP: Factors associated with complications in microvascular reconstruction of head and neck defects. Plast. Reconst. Surg. 103(2), 403-411 (1999).
29. Grant CA, Dempsey GA, Lowe D, Brown JS, Vaughan ED, Rogers SN: APACHE II, scoring for the prediction of immediate surgical consequences in head and neck cancer patients. Plast Recons. Surg. 119(6), 1751-1758 (2007).
30. Iype EM, Pandey M, Mathew A, Thomas G, Nair MK: Squamous cell carcinoma of the buccal mucosa in young adults. Br. J. Oral Maxillofac. Surg. 42(3), 185-189 (2004).
31. Fioretti F, Bosetti C, Tavani A, Franceschi S, La Vecchia C: Risk factors for oral and pharyngeal cancer in never smokers. Oral Oncol. 35(4), 375-378 (1999).
32. Matullo G, Dunning AM, Guarrera S et al.: DNA repair polymorphisms and cancer risk in non-smokers in a cohort study. Carcinogenesis 27(5), 997-1007 (2006).
33. Nishimoto IN, Pinheiro NA, Rogatto SR et al.: Cyclin D1 gene polymorphism as a risk factor for squamous cell carcinoma of the upper aero-digestive tract in non-smokers. Oral Oncol. 40(6), 604-610 (2004).
34. Kuroda Y, Nakao H, Ikemura K, Katoh T: Association between the TP53 codon 72 polymorphism and oral cancer risk and prognosis. Oral Oncol. 43(10), 1043-1048 (2007).
35. Fakhry C, Westra WH, Li S et al.: Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J. Natl Cancer Inst. 100(4), 261-269 (2008).
36. Kuo KT, Hsiao GH, Lin CH et al.: The biomarkers of human papillomavirus infection in tonsillar squamous cell carcinoma - molecular basis and predicting favourable outcome. Mod. Pathol. 21(4), 376-386 (2008).
37. Klozar J, Kratochvil V, Salakova M et al.: HPV status and regional metastasis in the prognosis of oral and oropharyngeal cancer. Eur. Arch. Otorhinolaryngol. 265(Suppl. 1), S75-S82 (2008).
38. Kreimer AR, Clifford GM, Boyle P et al.: Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review. Cancer Epidemiol. Biomarkers Prev. 14(2), 467-475 (2005).
39. O'Hanlon S, Forster DP, Lowry RJ: Oral cancer in the North-East of England: incidence, mortality trends and the link with material deprivation. Community Dent. Oral Epidemiol. 25(5), 371-376 (1997).
40. Greenwood M, Thompson PJ, Lowry Rj, Steen IN; Oral cancer material deprivation, unemployment and risk factor behaviour - an initial study. Int. J. Oral Maxillolac. Surg. 32(1), 74-77 (2003).
41. Rogers SN, Pabla R, McSorley A, Lowe D, Brown JS, Vaughan ED: An assessment of deprivation as a factor in the delays of presentation, diagnosis and treatment in patients with oral and oropharyngeal squamous cell carcinoma. Oral Oncol. 43(7), 648-655 (2007).
42. Wong YK, Tsai WC, Lin JC et al.: Socio-demographic factors in the prognosis of oral cancer patients. Oral Onrol. 42(9), 893-906 (2006).
43. Gorsky M, Epstein JB, Oakley C, Le ND, Stevenson-Moore P: Carcinoma of the tongue: a case series analysis of clinical presentation, risk factors, staging and outcome. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 98(5), 546-552 (2004).
44. Woolgar JA, Scott J, Vaughan ED, Brown JS, West CR, Rogers S: Survival, metastasis and recurrence of oral cancer in relation to pathological features. Ann. R. Coll. Surg Engl. 77(5), 325-331 (1995).
45. Sutton DN, Brown JS, Rogers SN, Vaughan ED, Woollgar JA: The prognostic implication of the surgical margin in oral squamous cell carcinoma. Int. J. Oral Maxillofac. Surg. 32(1), 30-34 (2003).
46. Woolgar JA, Rogers S, West CR, Errington RD, Brown JS, Vaughan F.D: Survival and patterns of recurrence in 200 oral cancer patients created by radical surgery and neck dissection. Oral Oncol. 35(3), 257-265 (1999).
47. Lo WL, Kao Sy, Chi LY, Wong YK, Chang RC: Outcomes of oral cancer in Taiwan after surgical therapy: factors affecting survival. J. Maxillofac. Surg. 61(7), 751-758 (2003).
48. Gonzalez-Moles MA, Esteban F, Rodriguez-Archilla A, Ruiz-Avila I, Gonzalez-Moles S: Importance of tumour thickness measurement in prognosis of tongue cancer. Oral Oncol. 38(4), 394-397 (2002).
49. Weijers M, Snow GB, Bezemer PD, van der Wal JE, van der Waal I: The clinical relevance of epithelial dysplasia in the surgical margins of tongue and floor of mouth squamous cell carcinoma: an analysis of 37 patients. J. Oral Path. Med. 31(1), 11-15 (2002).
50. Woolgar JA, Triantafyllou A: Pitfalls and procedures in the diagnosis of oral and oropharyngeal squamous cell carcinoma and a review of the role of pathology in prognosis. Oral Oncol. (2008) (Epub ahead of print).
51. Rusthoven K, Ballonoff A, Raben D, Chen C: Poor prognosis in patients with stage I and II oral tongue squamous cell carcinoma. Cancer 112(2), 345-351 (2008).
52. Po Wing Yuen A, Lam KY, Lam LK et al.: Prognostic factors of clinically stage I and II oral tongue carcinoma - a comparative study of stage, thickness, shape, growth pattern, invasive front malignancy grading, Martinez-Gimenco score and pathologic features. Head Neck 24(6), 513-520 (2002).
53. O-charoenat P, Pillai G, Patel S et al.: Tumour thickness predicts cervical nodal metastasis and survival in early oral tongue cancer. Oral Oncol. 39(4), 386-390 (2003).
54. Liao CT, Chang JT, Wang HM et al.: Analysis of risk factors of predictive local tumour control in oral cavity cancer. Ann. Surg. Oncol. 15(3), 915-922 (2008).
55. Wallwork BD, Anderson SR, Conman WB: Squamous cell carcinoma of the floor of mouth: tumour thickness and the rate of cervical metastasis. ANZ J. Surg. 77(9), 761-764 (2007).
56. Sparano A, Weinstein G, Chalian A, Yodul M, Webwer R: Multivariate predictors of outcome of occult neck metastasis in early tongue cancer: Otolaryngol. Head Neck Surg. 131(4), 472-476 (2004).
57. Ambrosch P, Kron M, Fischer G, Brinck U: Micrometastases in carcinoma of the upper aerodigestive tract: detection, risk of metastasizing and prognostic value of depth of invasion. Head Neck 17(6), 473-479 (1995).
58. Mohit-Tabatabai MA, Sobel HJ, Rush BF, Mashberg A: Relation of thickness of floor of mouth stage I and II cancers to regional metastasis. Am. J. Surg. 152(4), 351-353 (1986).
59. World Health Organization Classification of Tumours. Pathology & Genetics. Head and Neck Tumours Barnes L, Eveson JW, Reichart P, Sidransky D (Eds). IARC Press, Lyon (2005).
60. Broders AC: Squamous cell epithelioma of the lip: a study of 537 cases. JAMA 74, 656-664 (1920).
61. Anneroth G, Batsakis J, Luna M: Review of the literature and a recommended grading system of malignancy grading in oral squamous cell carcinoma. Scand. J. Dent. Res. 95(3), 229-249 (1987).
62. Bryne M, Jenssen N, Boysen M: Histological grade in the deep invasive front of T1 and T2 glottic squamous cell carcinoma has high prognostic value. Virchows Arch. 427(3), 277-281(1995).
63. Sawair FA, Irwin CR, Gorgon DJ, Leonard AG, Stephenson SS, Napier SS: Invasive front grading: reliability and usefulness in the management of oral squamous cell carcinoma. J. Oral Path. Med. 32(1), 1-9 (2003).
64. Odell EW, Jani P, Sherriff M, Ahluwalia SM, Hibbert J, Levison D: The prognostic value of individual histological grading parameters in small lingual squamous cell carcinoma. The importance of pattern of invasion. Cancer 74(3), 789-794 (1994).
65. Kurokawa H, Zhang M, Matsumoto S et al.: The high prognostic value of the histological grade at the deep invasive front of tongue squamous cell carcinoma. J. Oral Path. Med. 34(6), 329-333 (2005).
66. Spiro RH, Guillamondegui O Jr, Paulino, AF, Huvos AG: Pattern of invasion and margin assessment in patients with oral tongue cancer. Head Neck 21(5), 408-413 (1999).
67. Brandwein-Gensler M, Teixeira MS, Lewis CM et al.: Oral squamous cell carcinoma: histological risk assessment but not margin status is strongly predictive of local disease free and overall survival. Am. J. Surg. Pathol. 29(2), 167-178 (2005).
68. Helliwell TR, Woolgar JA: Minimum dataset for histopathological reporting common cancers: Minimum dataset for head and neck carcinomas and salivary neoplasms. The Royal College of Pathologists, London, UK (2005).
69. Chandu A, Adams G, Smith AC: Factors affecting survival in patients with oral cancer: an Australian perspective. Int. J. Oral Maxillofac. Surg. 34(5), 514-520 (2005).
70. Rahima B, Shingaki S, Nagata M, Saito C: Prognostic significance or perineural invasion in oral and oropharyngeal carcinoma. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 97(4), 423-431 (2004).
71. Garzino-Demo P, Dell'Acqua A, Dalmasso P et al.: Clinicopathological parameters and outcomes of 245 patients operated for oral squamous cell carcinoma. J. Craniomaxillofac. Surg. 34(6), 344-350 (2006).
72. Shaw RJ, Brown JS, Woolgar JA, Lowe D, Rogers SN, Vaughan ED: The influence of the pattern of mandibular invasion on recurrence and survival in oral squamous cell carcinoma. Head Neck 26(10), 861-869 (2004).
73. Liao CT, Chang JT, Wang HM et al.: Survival in squamous cell carcinoma of the oral cavity: differences between pT4N0 and other stage IV categories. Cancer 110(3), 564-571 (2007).
74. O'Brien CJ, Carter RL, Knee-Chee S et al.: Invasion of the mandible by squamous carcinomas of the oral cavity and oropharynx. Head Neck Surg. 8, 247-256 (1986).
75. O'Brien CJ, Adams JR, McNeil RB et al.: Influence of bone invasion and extent of mandibular resection on local control of cancers of the oral cavity and oropharynx. Int. J. Oral Maxillofac. Surg. 32, 492-497 (2003).
76. Cole RD, McGuirt WF: Prognostic significance for skin involvement for mucosal tumours of the head and neck. Arch. Otolaryngol. Head Neck Surg. 121(11), 1246-1248 (1995).
77. Pereira MC, Oliveira DT, Landman G, Kowalski LP: Histologic subtypes of oral squamous cell carcinoma: prognostic relevance. J. Can. Dent. Assoc. 73(4), 339-344 (2007).
78. Napier SS, Gormley JS, Newlands C: Adenosquamous carcinoma. A rare neoplasm with an aggressive course. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 79(5), 607-611 (1995).
79. Soriano E, Faure C, Lantuejoul S et al.: Course and prognosis of basaloid squamous cell carcinoma of the head and neck: a case-control study of 62 patients. Eur. J. Cancer 44(2), 244-250 (2008).
80. Ide F, Shimoyama, Horie N, Kusama K: Basaloid squamous cell carcinoma of the oral mucosa: report of a new case and review of 45 cases in the literature. Oral Oncol. 38(1), 120-124 (2002).
81. Woolgar JA, Triantafyllou A: A histopathological appraisal of surgical margins in oral and oropharyngeal cancer resection specimens. Oral Oncol. 41(10), 1034-1043 (2005).
82. Cheng A, Cox D, Schmidt BL: Oral squamous cell carcinoma margin discrepancy after resection and pathologic processing. J. Oral Maxillofac. Surg. 66(3), 523-529 (2008).
83. Layland M, Sessions DG, Lenox J: The influence of lymph node metastasis in the treatment of squamous cell carcinoma of the oral cavity, oropharynx, larynx and hypopharynx: N0 vs N+. Laryngoscope 115(4), 629-639 (2005).
84. Shah J: Cervical lymph node metastasis: its diagnostic, therapeutic and prognostic implications. Oncology 4(10), 61-69 (1990).
85. Woolgar JA, Rogers SN, Lowe D, Brown JS, Vaughan ED: Cervical lymph node metastasis: the importance of even microscopic extracapsular spread. Oral Oncol. 39(2), 130-137 (2003).
86. Greenberg JS, Fowler R, Gomez J et al.: Extent of extracapsular spread: a clinical prognosticator in oral tongue cancer. Cancer 97(6), 1464-1470 (2003).
87. Puri SK, Fan CY, Hanna E: Significance of extracapsular lymph node metastasis in patients with head and neck squamous cell carcinoma. Curr. Opin. Otolaryngol. Head Neck Surg. 11(2), 119-123 (2003).
88. Ferlito A, Rinlado A, Devaney KO et al.: Prognostic significance of microscopic and macroscopic extracapsular spread from metastatic tumour in the cervical lymph nodes. Oral Oncol. 38(8), 747-751 (2002).
89. Shingaki S, Nomura T, Takada M, Kobayashi T, Suzuki I, Nakajima T: The impact of extranodal spread of lymph node metastasis in patients with oral cancer. Int. J. Oral Maxillofac. Surg. 28(4), 279-284 (1999).
90. Alvi A, Johnson JT: Extracapsular spread in the clinically negative neck (N0): implications and outcome. Otolaryngol. Head Neck Surg. 114(1), 65-70 (1996).
91. Ferlito A, Rinaldo A, Devaney KO, Nakashiro K, Hamakawa H: Detection of lymph node micrometastases in patients with squamous cell carcinoma of the head and neck. Eur. Arch. Otolaryngol. 265(10), 1147-1153 (2008).
92. Woolgar JA: Micrometastasis in oral/oropharyngeal squamous cell carcinoma: incidence, histopathological features and clinical implications. Br J. Oral Maxillofac. Surg. 37(3), 181-186 (1999).
93. Rhee D, Wenig BM, Smith RV: The significance of immunohistochemically detected micrometastasis in patients with squamous cell carcinoma of the head and neck. Laryngoscope 112(11), 1970-1974 (2002).
94. Van den Brekel MW, Stel HV, van der Valk P, Van der Waal I, Meyer CJ, Snow GB: Micrometastasis from squamous cell carcinoma in neck dissection specimens. Eur. Arch. Otolaryngol. 249(6), 349-353 (1992).
95. Bouquot JE, Weiland LH, Kurland LT: Metastases to and from the upper aerodigestive tract. Head Neck 11(3), 212-218 (1989).
96. Kademani D, Bell RB, Bagheri S et al.: Prognostic factors in intraoral squamous cell carcinoma: the influence of histological grade. J. Oral Maxillofac. Surg. 63(11), 1599-1601 (2005).
97. Choi KK, Kim MJ, Yuri PY et al.: Independent prognostic factors of 861 cases of oral squamous cell carcinoma in Korean adults. Oral Oncol. 42(2), 208-217 (2006).
98. Thompson PJ: Field change and oral cancer: new evidence for widespread carcinogenesis? Int. J. Oral Maxillofac. Surg. 31(3), 262-266 (2002).
99. Lin K, Patel SG, Chu PY et al.: Second primary malignancy of the aerodigestive tract in patients treated for cancer of the oral cavity and larynx. Head Neck 27(12), 1042-1048 (2005).
100. Chuang SC, Scelo G, Tonita JM et al.: Risk of second primary cancer among patients with head and neck cancers: A pooled analysis of 13 cancer registries. Int. J. Cancer 123(10), 2390-2396 (2008).
101. Bhattacharyya N, Nayak VK: Survival outcomes for second primary head and neck cancer: a matched analysis. Otolaryngol. Head Neck Surg. 132(1), 63-68 (2005).
102. Fan KF, MacBean AD, Putcha V, McGurk M: Perioperative complications and survival in patients with oral cancer. Ann. R. Australas. Coll. Dent. Surg. 17, 35-40 (2004).
103. McGurk MG, Fan KF, MacBean AD, Putcha V: Complications encountered in a prospective series of 182 patients treated surgically for mouth cancer. Oral Oncol. 43(5), 471-476 (2007).
104. De Melo GM, Ribeiro KC, Kowalski LP, Deheinzelin D: Risk factors for postoperative complications in oral cancer and their prognostic significance. Arch. Otolaryngol. Head Neck Surg. 127(7), 828-833 (2001).
105. De Cassia Braga Ribeiro K, Kowalski LP, Latorre Mdo R: Perioperative complications, comorbidities and survival in oral and oropharyngeal cancer. Arch. Otolaryngol. Head Neck Surg. 129(2), 219-228 (2003).
106. Gueret G, Bourgain JL, Luboinski B: Sudden death after head and neck surgery. Curr. Opin. Otolaryngol. Head Neck Surg. 14(2), 89-94 (2006).
107. Sargeran K, Murtomaa H, Safavi SM, Vehkalahti MM, Teronen, O: Survival after diagnosis of cancer of the oral cavity. Br. J. Oral Maxillofac. Surg. 46(3), 187-191 (2008).
108. Calhoun KH, Fulmer P, Weiss R: Distant metastases from head and neck squamous cell carcinoma. Laryngoscope 104(10), 1199-1205 (1994).
109. Lim YC, Koo BS, Choi EC: Bilateral lymph node metastasis: a predictor of isolated distant metastasis in patients with oral and oropharyngeal squamous cell carcinoma after primary curative surgery. Laryngoscope 117(9), 1576-1580 (2007).
110. Liao CT, Wang HM, Chang JT, Ng SH, Hsueh C, Lee YH: Analysis of risk factors for distant metastases in squamous cell carcinoma of the oral cavity. Cancer 110(7), 1501-1508 (2007).
111. Slootweg PJ, Hordijk GJ, Koole R: Autopsy findings in patients with head and neck squamous cell cancer and their therapeutic relevance. Eur. J. Cancer B. Oral Oncol. 32B(6), 413-415 (1996).
112. Choi HR, Roberts DB, Johnigan RH. Molecular and clinicopathologic comparisons of head and neck squamous cell carcinoma variants: common and distinctive features of biological significance. Am. J. Surg. Pathol. 28(10), 1299-1310 (2004).
113. Coon SW, Savera AT, Zarbo RJ et al.: Prognostic implications of loss of heterozygosity at 8p21 and 9p21 in head and neck squamous cell carcinoma. Int. J. Cancer 111(2), 206-212 (2004).
114. Agada FO, Patmore H, Alhamarneh O et al.: Genetic profile of head and neck squamous cell carcinoma: clinical implications. J. Laryngol. Otol. 11, 1-7 (2008).
115. de Oliveira LR, Ribeiro-Silva A, Zucoloto S. Prognostic impact of p53 and p63 immunoexpression in oral squamous cell carcinoma. J. Oral Path. Med. 36(4), 191-197 (2007).
116. Nylander K, Pabelsteen E, Hall PA: The p53 molecule and its prognostic role in squamous cell carcinomas of the head and neck. J. Oral Path. Med. 29(9), 413-425 (2000).
117. Atula T, Hedstrom J, Ristimaki A et al.: Cyclooxygenase-2 expression in squamous cell carcinoma of the oral cavity and pharynx: association to P53 and clinical outcome. Oncal. Rep. 16(3), 485-490 (2006).
118. Fuwa N, Kodaira T, Furutani K, Tachibana H, Nakamura T, Daimon T: Chemoradiation therapy using radiotherapy, systemic chemotherapy with 5-fluorouracil and nedaplatin, and intra-arterial infusion using carboplatin for locally advanced head and neck cancer - Phase II study. Oral Oncol. 43(10), 1014-1020 (2007).
119. Dietz A, Boehm A, Mozet C, Wichmann G, Giannis A: Current aspect of targeted therapy in head and neck tumours. Eur. Arch. Otolaryngol. 265(Suppl. 1), S3-S12 (2008).
120. Caponigro F, Milano A, Basile M, Ionna F, Iaffaioli RV: Recent advances in head and neck cancer therapy: the role of new cyrotoxic and molecular-targeted agents. Curr. Opin. Oncol. 18(3), 247-252 (2006).
121. Caudell JJ, Sawrie SM, Spencer SA et al.: Locoregionally advanced head and neck cancer treated with primary radiotherapy: a comparison of the addition of cetuximab or chemotherapy and the impact of protocol treatment. Int. J. Radiat. Oncol. Biol. Phys. 71(3), 676-681 (2008).
122. Huang X, Pateromichelakis S, Hills A et al.: p53 mutations in deep tissues are more strongly associated with recurrence than mutation-positive mucosal margins. Clin. Cancer Res. 13 (20), 6099-6106 (2007).
123. Shaw RJ, Hall GL, Woolgar JA et al.: Novel epigenetic assays in the analysis of resection margins and lymph nodes in oral squamous cell carcinoma. Br. J. Oral Maxillofac. Surg. 45(8), 617-622 (2007).
124. Campo-Trapero J, Cano-Sanchez J, Palacios-Sanchez B et al.: Update on molecular pathology in oral cancer and precancer. Anticancer Res. 28 (2B), 1197-1205 (2008).